Ottawa Research Institute Latest Casualty of U.S. Economic Policy

Ottawa – The Ottawa Hospital Research Institute (OHRI), a leading biomedical and clinical research center in Canada’s capital, has become the latest target of economic actions emanating from the Trump administration. Sources within the institute confirmed this week that new, stringent restrictions have been placed on collaborations with OHRI researchers, particularly concerning federal funding opportunities and data sharing initiatives.

These actions are allegedly stemming from a broader policy shift aimed at prioritizing domestic research and development, even at the expense of longstanding partnerships with international institutions. Details remain scarce, but indications point towards a tightening of regulations that make it significantly more difficult for U.S. federal funding to be channeled towards collaborative projects involving Canadian researchers, specifically those working at OHRI.

“We are deeply concerned about the potential impact this could have on our ongoing research projects, many of which are collaborative efforts with U.S. institutions,” said Dr. Vivian Nguyen, a senior researcher at OHRI specializing in cancer therapies, who spoke on condition of anonymity, fearing repercussions. “These collaborations are vital for accelerating scientific discovery and developing innovative treatments that benefit patients on both sides of the border."